SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-051339
Filing Date
2023-04-27
Accepted
2023-04-27 16:11:18
Documents
4
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm232131-2_def14a.htm DEF 14A 435768
2 GRAPHIC sg_davidpluci-bw.jpg GRAPHIC 35841
3 GRAPHIC px_01page-bw.jpg GRAPHIC 585667
4 GRAPHIC px_02page-bw.jpg GRAPHIC 560149
  Complete submission text file 0001104659-23-051339.txt   1827403
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40536 | Film No.: 23856955
SIC: 2834 Pharmaceutical Preparations